ProShares Ultra Nasdaq Biotechnology (BIB)

Add to Watchlists
Create an Alert
45.85 -1.36  -2.88% NASDAQ May 20, 20:00 Delayed 2m USD
View Full Chart
BIB Price Chart

BIB Performance

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -5.17% -5.04% -- --
3M -17.04% -17.08% -- --
6M -4.28% -4.38% -- --
YTD 8.93% 8.06% -- --
1Y -16.98% -17.09% -- --
3Y 3.48% 3.44% -- --
5Y 4.59% 4.56% -- --
10Y -- -- -- --
15Y -- -- -- --
20Y -- -- -- --
As of May 20, 2019. Returns for periods of 1 year and above are annualized.

BIB Asset Allocation

Type % Net % Long % Short
Cash -100.3% 1.80% 102.1%
Stock 139.1% 139.1% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 61.28% 61.28% 0.00%
As of April 30, 2019
View More Holdings

BIB Top 10 Holdings

Symbol Name % Weight Price % Chg
-- Nasdaq Biotechnology Index Swap Deutsche Bank Ag 40.87% -- --
-- Nasdaq Biotechnology Index Swap Societe Generale 17.64% -- --
-- Nasdaq Biotechnology Index Swap Ubs Ag 13.22% -- --
-- Ishares Biotech (Ibb) Swap Goldman Sachs International 8.72% -- --
CELG Celgene Corp 8.41% 95.08 +0.26%
GILD Gilead Sciences Inc 8.33% 66.23 +0.56%
AMGN Amgen Inc 7.86% 170.40 +1.19%
BIIB Biogen Inc 5.71% 230.50 -0.11%
-- Nasdaq Biotechnology Index Swap Goldman Sachs International 5.62% -- --
VRTX Vertex Pharmaceuticals Inc 5.47% 166.82 +0.66%
As of April 30, 2019
Advertisement

BIB Basic Info

Style
Equity Style Mid Cap/Growth
Broad Asset Class Alternative
Broad Category Alternative
Category Name Trading--Leveraged Equity
Prospectus Objective Specialty - Technology
Fund Owner Firm Name ProShares
Benchmark Index
NASDAQ Biotechnology TR USD
200.0%

BIB Manager Info

Name Tenure
Michael Neches 5.50 yrs
Tarak Davé 0.92 yrs

BIB Net Fund Flows

1M 30.18M
3M 8.788M
6M -54.34M
YTD -12.06M
1Y -87.02M
3Y -288.77M
5Y -123.16M
10Y --
As of April 30, 2019

BIB Risk Info

Beta (5Y) 2.740
Max Drawdown (All) 67.24%
Historical Sharpe Ratio (10Y) --
Historical Sortino (All) 1.171
30-Day Rolling Volatility 47.43%
Daily Value at Risk (VaR) 1% (All) 8.19%
Monthly Value at Risk (VaR) 1% (All) 31.68%

BIB Comparables

Edit

BIB Attributes

Key Dates
Inception Date 4/6/2010
Termination Date
Last Annual Report Date 5/31/2018
Last Prospectus Date 4/5/2019
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund Yes
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

Excel Add-In Codes

  • Name: =YCI("BIB","name")
  • Broad Asset Class: =YCI("BIB", "broad_asset_class")
  • Broad Category: =YCI("BIB", "broad_category_group")
  • Prospectus Objective: =YCI("BIB", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.